The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation represents a challenge in clinical …

Background The objective of this article is to summarize the published literature concerning
the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently …

Dabigatran etexilate is an oral, reversible direct thrombin inhibitor that is approved in the EU
and several other countries for the prevention of venous thromboembolism after elective hip …

The Hemostatic System as a Modulator of Atherosclerosis | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …

Late-breaking clinical trials presented at the 2009 annual scientific meetings of the ACC,
AHA, and European Society of Cardiology (ESC), as well as selected other data reported …

Objectives: This study sought to evaluate whether prasugrel may serve as an alternative to
clopidogrel in patients with triple therapy. Background: Approximately 10% of patients who …

The optimal regimen of the anticoagulant and antiplatelet therapies in patients with atrial
fibrillation who have had a coronary stent is unclear. It is well recognised that “triple therapy” …

Oral warfarin is associated with extensive food and drug interactions, and there is a need to
consider such interactions with the new oral anticoagulants (OACs) dabigatran etexilate …

The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation is an emerging clinical problem …

An alkaloid is a class of naturally occurring organic nitrogen-containing compounds that are
frequently found in the plant kingdom. Many alkaloids are valuable medicinal agents that …